NewMediaWire
NRx Pharmaceuticals (NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment
📈
AI Sentiment
Highly Positive
8/10
NRX Pharmaceuticals Inc. News
Latest updates and market news for NRXP
7 news
Nov 29 - Dec 5, 2025
Page 1
GlobeNewswire
NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation
📈
AI Sentiment
Highly Positive
8/10
NewMediaWire
NRx Pharmaceuticals (NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date
📊
AI Sentiment
Positive
7/10
GlobeNewswire
NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREEâ„¢, a Preservative-Free IV Ketamine
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
📊
AI Sentiment
Positive
6/10
GlobeNewswire
NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference
📈
AI Sentiment
Highly Positive
8/10
Share this news page